Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT06947993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT06947993
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Interventions
- GHZ339 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2025
- Primary completion
- Nov 26, 2028
- Completion
- Dec 21, 2028
- Last update posted
- Dec 21, 2025
2025 – 2028
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35233 | Recruiting |
| Novartis Investigative Site | Birmingham | Alabama | 35244 | Recruiting |
| Novartis Investigative Site | Fort Smith | Arkansas | 72916 | Recruiting |
| Novartis Investigative Site | Fountain Valley | California | 92708 | Recruiting |
| Novartis Investigative Site | Los Angeles | California | 90056 | Recruiting |
| Novartis Investigative Site | Sacramento | California | 95815 | Recruiting |
| Novartis Investigative Site | Santa Ana | California | 92701 | Recruiting |
| Novartis Investigative Site | Santa Monica | California | 90404 | Recruiting |
| Novartis Investigative Site | Washington D.C. | District of Columbia | 20060 | Recruiting |
| Novartis Investigative Site | Miami | Florida | 33144 | Recruiting |
| Novartis Investigative Site | Atlanta | Georgia | 30342 | Recruiting |
| Novartis Investigative Site | Macon | Georgia | 31217 | Recruiting |
| Novartis Investigative Site | Louisville | Kentucky | 40241 | Recruiting |
| Novartis Investigative Site | Brighton | Massachusetts | 02135 | Recruiting |
| Novartis Investigative Site | Troy | Michigan | 48084 | Recruiting |
| Novartis Investigative Site | Saint Joseph | Missouri | 64506 | Recruiting |
| Novartis Investigative Site | Brooklyn | New York | 11203 | Recruiting |
| Novartis Investigative Site | Arlington | Texas | 76011 | Recruiting |
| Novartis Investigative Site | Cypress | Texas | 77433 | Recruiting |
| Novartis Investigative Site | Dallas | Texas | 75235-9069 | Recruiting |
| Novartis Investigative Site | Houston | Texas | 77030 | Recruiting |
| Novartis Investigative Site | San Antonio | Texas | 78218 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06947993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2025 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06947993 live on ClinicalTrials.gov.